Keyphrases
Septic Shock
80%
Intensive Care Unit
55%
Critically Ill Patients
51%
Sepsis
46%
Sepsis Shock
44%
Antimicrobial Resistance
36%
Lung
33%
COVID-19
32%
Confidence Interval
32%
Lung Transplantation
31%
Severe Sepsis
30%
Bronchoalveolar Lavage
30%
Ventilator-associated Pneumonia
30%
Mechanical Ventilation
29%
Methicillin-resistant Staphylococcus Aureus
25%
Odds Ratio
24%
Pneumonia
24%
Gram-negative Bacteria
23%
Critical Care
23%
Gram-negative Bacilli
22%
Retrospective Cohort Study
21%
Antibiotic Resistance
20%
Gram-negative
20%
Patients at Risk
20%
Contact Tracing
20%
Critically Ill
20%
Antibiotics
20%
Cefepime
18%
Ceftriaxone
18%
Acute Respiratory Distress Syndrome
17%
Risk Factors
17%
Empiric Antibiotics
17%
Epidemiology
17%
Septic Patients
16%
Acinetobacter
16%
Antimicrobial
16%
Healthcare Workers
15%
Multidrug-resistant Pathogens
14%
Meropenem
14%
Community-acquired Pneumonia
14%
Adult Patients
14%
Hospitalized Patients
13%
Multidrug-resistant Gram-negative Bacteria
13%
Ventilation Rate
13%
US Hospitals
13%
Determinants of Outcome
13%
Infection Recurrence
12%
Severe COVID-19
12%
Skin Tissue
12%
Soft Tissue Infection
12%
Medicine and Dentistry
Infection
89%
Pathogen
64%
Sepsis
63%
Septic Shock
56%
Antibiotic Resistance
40%
COVID-19
40%
Intensive Care Unit
36%
Gram-Negative Bacteria
33%
Lung Transplantation
31%
Diagnosis
28%
Lung Lavage
27%
Lung
25%
Artificial Respiration
23%
Antiinfective Agent
23%
Cohort Effect
22%
Cytokine
21%
Acute Respiratory Distress Syndrome
20%
Ventilator-Associated Pneumonia
20%
Severe Acute Respiratory Syndrome Coronavirus 2
18%
Antibiotics
17%
Odds Ratio
17%
Retrospective Cohort Study
16%
Methicillin Resistant Staphylococcus Aureus
15%
Acinetobacter
15%
Antibiotic Therapy
14%
Transplantation
14%
Clinician
14%
Bloodstream Infection
14%
Antimicrobial Therapy
12%
Lung Nodule
12%
Gram-Positive Bacteria
12%
Cefepime
12%
Interleukin 6
12%
Breathing
11%
Soft Tissue Infection
11%
Respiratory Failure
11%
Multidrug Resistance
11%
Meropenem
11%
Broad-Spectrum Antibiotic
11%
Intensive Care
10%
Steady State
10%
Contact Examination
10%
Decision Making
10%
Reverse Transcription Polymerase Chain Reaction
10%
Multilevel Analysis
10%
Rapid Response Team
10%
Receptor Blocking Agent
10%
Lung Biopsy
10%
Interleukin 6 Receptor
10%
Hospital-Acquired Pneumonia
10%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Infectious Agent
66%
Septic Shock
64%
Sepsis
63%
Gram Negative Bacterium
44%
Antimicrobial Resistance
43%
Antibiotics
31%
Diseases
29%
Cohort Study
28%
Methicillin-Resistant Staphylococcus Aureus
23%
Cytokine
22%
Adult Respiratory Distress Syndrome
20%
Hospital Mortality
20%
Bloodstream Infection
18%
SARS Coronavirus
18%
Cefepime
17%
Ceftriaxone
17%
Acinetobacter
15%
Meropenem
14%
Gram Positive Bacterium
12%
Recurrent Disease
12%
Methicillin Resistant Staphylococcus Aureus Infection
12%
Antimicrobial Therapy
12%
Interleukin 6
12%
Pseudomonas aeruginosa
12%
Antiinfective Agent
12%
Antibiotic Therapy
11%
Soft Tissue Infection
11%
Respiratory Failure
11%
Multidrug Resistance
11%
Secondary Infection
10%
Coronavirinae
10%
Hospital Acquired Pneumonia
10%
Seasonal Influenza
10%
Mould
10%
Aspergillus
10%
Receptor Blocking Agent
10%
Mortality Rate
10%
Interleukin 6 Receptor
10%
Lung Nodule
10%
Aminoglycoside
10%
Crackle
10%
Candidemia
10%
Host Factor
10%
Piperacillin Plus Tazobactam
10%
Hypotension
10%
Cardiogenic Shock
10%
Microorganism
10%
Number Needed to Treat
10%
Macaca fascicularis
10%
